The chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancer

Carcinogenesis

Volumn 31, Issue 5, 2010, Pages 886-893

  Brown, Nadine M ^a   Belles, Carrie A ^a   Lindley, Stephanie L ^a   Zimmer Nechemias, Linda D ^a   Zhao, Xueheng ^a   Witte, David P ^a   Kim, Mi Ok ^a,b   Setchell, Kenneth D R ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EQUOL; ESTROGEN RECEPTOR; ANTINEOPLASTIC AGENT; ISOFLAVONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BREAST CANCER; BREAST CARCINOGENESIS; CANCER PREVENTION; CHIRALITY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG BLOOD LEVEL; DRUG STRUCTURE; ENANTIOMER; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; LATENT PERIOD; NONHUMAN; PRIORITY JOURNAL; RAT; UTERUS WEIGHT; ANIMAL; BLOOD; CANCER INVASION; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; EXPERIMENTAL NEOPLASM; NECROSIS; PATHOLOGY; SPRAGUE DAWLEY RAT; STEREOISOMERISM;

ANIMALS; ANTICARCINOGENIC AGENTS; BODY WEIGHT; DISEASE MODELS, ANIMAL; FEMALE; ISOFLAVONES; MAMMARY NEOPLASMS, EXPERIMENTAL; NECROSIS; NEOPLASM INVASIVENESS; RATS; RATS, SPRAGUE-DAWLEY; STEREOISOMERISM;

EID: 77952296394     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq025     Document Type: Article

References (63)

1. Messina, M.J. et al. (1994) Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer, 21, 113-131.
2. Barnes, S. (1995) Effect of genistein on in vitro and in vivo models of cancer. J. Nutr., 125, 777S-783S.
3. Messina, M.J. et al. (2001) Soy for breast cancer survivors: a critical review of the literature. J. Nutr., 131, 3095S-3108S.
4. Troll, W. et al. (1980) Soybean diet lowers breast tumor incidence in irradiated rats. Carcinogenesis, 1, 469-472.
5. Barnes, S. et al. (1990) Soybeans inhibit mammary tumors in models of breast cancer. Prog. Clin. Biol. Res., 347, 239-253.
6. Coward, L. et al. (1993) Genistein, daidzein, and their β-glycoside conjugates: antitumor isoflavones in soybean foods from American and Asian diets. J. Agric. Food Chem., 41, 1961-1967.
7. Akiyama, T. et al. (1987) Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem., 262, 5592-5595.
8. Kim, H. et al. (1998) Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways. Am. J. Clin. Nutr., 68, 1418S-1425S.
9. Lamartiniere, C.A. et al. (1995) Genistein suppresses mammary cancer in rats. Carcinogenesis, 16, 2833-2840.
10. Murrill, W.B. et al. (1996) Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis, 17, 1451-1457.
11. Lamartiniere, C.A. et al. (1998) Genistein alters the ontogeny of mammary gland development and protects against chemically-induced mammary cancer in rats. Proc. Soc. Exp. Biol. Med., 217, 358-364.
12. Allred, C.D. et al. (2001) Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res., 61, 5045-5050.
13. Ju, Y.H. et al. (2001) Physiological concentrations of dietary genistein dose-dependently stimulate growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in athymic nude mice. J. Nutr., 131, 2957-2962.
14. Brown, N.M. et al. (2001) Animal models impacted by phytoestrogens in commercial chow: implications for pathways influenced by hormones. Lab. Invest., 81, 735-747.
15. Muthyala, R.S. et al. (2004) Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R-and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg. Med. Chem., 12, 1559-1567.
16. Setchell, K.D.R. et al. (2005) A method for the enantioselective synthesis of chromenes US Patent 2007/0027329A1 and PCT WO 2007/016423A2.
17. Heemstra, J.M. et al. (2006) Total synthesis of (S)-equol. Org. Lett., 8, 5441-5443.
18. Setchell, K.D.R. et al. (2002) The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J. Nutr., 132, 3577-3584.
19. Morito, K. et al. (2001) Interaction of phytoestrogens with estrogen receptors α and β. Biol. Pharm. Bull., 24, 351-356.
20. Setchell, K.D.R. et al. (2005) S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am. J. Clin. Nutr., 81, 1072-1079.
21. Setchell, K.D.R. et al. (2006) Method of defining equol-producer status and its frequency among vegetarians. J. Nutr., 136, 2188-2193.
22. Constantinou, A.I. et al. (1996) Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones. Anticancer Res., 16, 3293-3298.
23. Lamartiniere, C.A. et al. (2002) Daidzein: bioavailability, potential for reproductive toxicity, and breast cancer chemoprevention in female rats. Toxicol. Sci., 65, 228-238.
24. Fritz, W.A. et al. (1998) Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. Carcinogenesis, 19, 2151-2158.
25. Setchell, K.D.R. et al. (2009) The pharmacokinetics of S-(-)equol administered as SE5-OH tablets to healthy postmenopausal women. J. Nutr., 139, 2037-2043.
26. Setchell, K.D.R. et al. (2009) The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers. Am. J. Clin. Nutr., 90, 1029-1037.
27. Russo, J. et al. (1990) Comparative study of human and rat mammary tumorigenesis. Lab. Invest., 62, 244-278.
28. Russo, I.H. et al. (1978) Developmental stage of the rat mammary gland as determinant of its susceptibility to 7, 12-dimethylbenz[a]anthracene. J. Natl Cancer Inst., 61, 1439-1449.
29. Russo, J. et al. (1990) Pathology of tumours in laboratory animals. Tumours of the rat. Tumours of the mammary gland. IARC Sci. Publ., 99, 47-78.
30. Russo, J. et al. (2004) "Biological and Molecular Basis of Breast Cancer". Springer-Verlag, Heidelberg, Germany.
31. Meyer, J.S. et al. (2005) Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index. Mod. Pathol., 18, 1067-1078.
32. Costa, I. et al. (2002) Histopathologic characterization of mammary neo-plastic lesions induced with 7,12 dimethylbenz(alpha)anthracene in the rat: a comparative analysis with human breast tumors. Arch. Pathol. Lab. Med., 126, 915-927.
33. Axelson, M. et al. (1982) The identification of the weak oestrogen equol [7-hydroxy-3-(4′-hydroxyphenyl)chroman] in human urine. Biochem. J., 201, 353-357.
34. Setchell, K.D.R. et al. (1984) Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am. J. Clin. Nutr., 40, 569-578.
35. Shutt, D.A. et al. (1972) Steroid and phyto-oestrogen binding to sheep uterine receptors in vitro. J. Endocrinol., 52, 299-310.
36. Tang, B.Y. et al. (1980) Effect of equol on oestrogen receptors and on synthesis of DNA and protein in the immature rat uterus. J. Endocrinol., 85, 291-297.
37. Kuiper, G.G. et al. (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology, 139, 4252-4263.
38. Casanova, M. et al. (1999) Developmental effects of dietary phytoestrogens in Sprague-Dawley rats and interactions of genistein and daidzein with rat estrogen receptors alpha and beta in vitro. Toxicol. Sci., 51, 236-244.
39. Magee, P.J. et al. (2006) Equol: a comparison of the effects of the racemic compound with that of the purified S-enantiomer on the growth, invasion, and DNA integrity of breast and prostate cells in vitro. Nutr. Cancer, 54, 232-242.
40. Jordan, V.C. et al. (1999) Tamoxifen, raloxifene, and the prevention of breast cancer. Endocr. Rev., 20, 253-278.
41. Gotoh, T. et al. (1998) Chemoprevention of N-nitroso-N-methylurea-induced rat mammary carcinogenesis by soy foods or biochanin A. Jpn. J. Cancer Res., 89, 137-142.
42. Constantinou, A.I. et al. (2001) Chemopreventive effects of soy protein and purified soy isoflavones on DMBA-induced mammary tumors in female Sprague-Dawley rats. Nutr. Cancer, 41, 75-81.
43. Setchell, K.D.R. et al. (2003) Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakes. J. Nutr., 133, 1027-1035.
44. Soule, H.D. et al. (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl Cancer Inst., 51, 1409-1416.
45. Choi, E.J. et al. (2009) Equol induces apoptosis through cytochrome c-mediated caspases cascade in human breast cancer MDA-MB-453 cells. Chem. Biol. Interact., 177, 7-11.
46. Lephart, E.D. et al. (2004) Dietary isoflavones alter regulatory behaviors, metabolic hormones and neuroendocrine function in Long-Evans male rats. Nutr. Metab. (Lond.), 1, 16.
47. Rachon, D. et al. (2007) Effects of dietary equol on body weight gain, intra-abdominal fat accumulation, plasma lipids, and glucose tolerance in ovariectomized Sprague-Dawley rats. Menopause, 14, 925-32.
48. Kishida, T. et al. (2008) Dietary soy isoflavone-aglycone lowers food intake in female rats with and without ovariectomy. Obesity (Silver Spring), 16, 290-297.
49. Maskarinec, G. et al. (2008) Soy intake is related to a lower body mass index in adult women. Eur. J. Nutr., 47, 138-144.
50. Lyons, P.M. et al. (1989) Reduction of food intake in the ovulatory phase of the menstrual cycle. Am. J. Clin. Nutr., 49, 1164-1168.
51. Gong, E.J. et al. (1989) Menstrual cycle and voluntary food intake. Am. J. Clin. Nutr., 49, 252-258.
52. Geary, N. et al. (2001) Deficits in E2-dependent control of feeding, weight gain, and cholecystokinin satiation in ER-alpha null mice. Endocrinology, 142, 4751-4757.
53. King, J.T. et al. (1949) The influence of estrogen on cancer incidence and adrenal changes in ovariectomized mice on calorie restriction. Cancer Res., 9, 436.
54. Kritchevsky, D. et al. (1986) Calories, fat and cancer. Lipids, 21, 272-4.
55. Macrae, F.A. (1993) Fat and calories in colon and breast cancer: from animal studies to controlled clinical trials. Prev. Med., 22, 750-766.
56. Medlock, K.L. et al. (1995) Effects of coumestrol and equol on the developing reproductive tract of the rat. Proc. Soc. Exp. Biol. Med., 208, 67-71.
57. Bennetts, H.W. et al. (1946) A specific breeding problem of sheep on sub-terranean clover pastures in Western Australia. Aust. J. Agric. Res., 22, 131-138.
58. Folman, Y. et al. (1966) The interaction in the immature mouse of potent oestrogens with coumestrol, genistein and other uterovaginotrophic compounds of low potency. J. Endocrinol., 34, 215-225.
59. Medlock, K.L. et al. (1995) The effects of phytoestrogens on neonatal rat uterine growth and development. Proc. Soc. Exp. Biol. Med., 208, 307-313.
60. Awoniyi, C.A. et al. (1998) Reproductive sequelae in female rats after in utero and neonatal exposure to the phytoestrogen genistein. Fertil. Steril., 70, 440-447.
61. Yee, S. et al. (2008) Acute and subchronic toxicity and genotoxicity of SE5-OH, an equol-rich product produced by Lactococcus garvieae. Food Chem. Toxicol., 46, 2713-2720.
62. Ishiwata, N. et al. (2009) New equol supplement for relieving menopausal symptoms: randomized, placebo-controlled trial of Japanese women. Menopause, 16, 141-148.
63. Ju, Y.H. et al. (2006) Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice. Carcinogenesis, 27, 856-863.